Global IVD Antibodies
Market Report
2025
IVD Antibodies Market Report 2025 (Global Edition)
As per Cognitive Market Research's latest published report, the Global IVD Antibodies market size will be $26,277.09 Million by 2028.IVD Antibodies Industry's Compound Annual Growth Rate will be 6.68% from 2023 to 2030.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of IVD Antibodies Market Report 2024.
Global IVD Antibodies Market Report 2024 Market Size Split by Type (Cardiac Markers, Tumor Markers, Kidney Injury Markers, Infection and Inflammation Antibodies), by Application (Immunology, Cancer, C...
As per Cognitive Market Research's latest published report, the Global IVD Antibodies market size will be $26,277.09 Million by 2028.IVD Antibodies Industry's Compound Annual Growth Rate will be 6.68% from 2023 to 2030.
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global IVD Antibodies Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6.68% |
| Market Split by Type |
|
| Market Split by Application |
|
| Market Split by End User |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of IVD Antibodies industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
IVD Antibodies Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
IVD Antibodies Market Report Description
Definition of IVD Antibodies
In Vitro Diagnostics (IVD) are tests that can detect disease, infections and other medical conditions. Antibodies are used in a many of IVD tests to detect and measure defined target molecules that include bacterial antigens or viral antigens.
These are also used in determination state of health in order to cure, alleviate, treat, or prevent disease or its consequences. Antibodies such as cytokines that can be used to diagnose an inflammatory or autoimmune condition; and different biomarkers for cancer, cardiovascular disease, and neurological disorders.
Antibodies have great specificity and sensitivity, allowing them to detect even low-abundance analyses in a variety of sample types. IVD antibodies are popular because they are simple to utilize for diagnosis in laboratories, hospitals, and even at home.
Antibodies are mainly used in various methods including immunonephelometric, sandwich ELISA, lateral flow, and electrochemiluminescence and immunohistochemical pathology fields.
Nowadays, incidence of cancer and cardiovascular diseases is rapidly increasing across the globe. Similarly increasing prevalence of chronic disease such as HIV, hepatitis, and others is driving the demand for IVD antibodies in diagnostics laboratories around the world.
IVD Antibodies Market Size
What is Driving IVD Antibodies Market?
-
Increasing prevalence of cancer and infectious disease
The constantly changing lifestyle of the population across the globe is been noticed at a wider scale. The adoption of the non-healthy habits such as consumption of alcohol, tobacco, irregular and improper diet enhances the prevalence of cancer.
Moreover, exposure of DNA to the carcinogenic substances and radiation present in environment led to the mutation causing cancer. These carcinogenic substances penetrate the body through food, air and water may contribute to the development of cancer. The International Agency for Research on Cancer has estimated that globally, 1 in 5 people develop cancer during their lifetime, and 1 in 11 women and 1 in 8 men die from the disease.
Increasing in the infectious agents, like viruses, bacteria, and parasites (such as HBV and HCV, HTLV-1, Merkel Cell Polyomavirus, and Human Papillomaviruses among others) may lead to the increased risk of cancer. The infectious agents not only disrupt the cell growth and proliferation but also weaken the immune system which considerably decreases the body’s ability to fight cancer-causing infections. Some of the viruses, bacteria and parasites also cause chronic inflammation which lead to cancers.
According to estimates from the World Health Organization (WHO) in 2019, cancer is first or second leading cause of death in the population before 70 years. It is also considered as the vital barrier to increasing life expectancy across the world. The GLOBOCAN 2020 has estimated 19.3 million new cancer cases worldwide excluding 18.1 million non-melanoma skin cancer and approx. 10.0 million cancer deaths (9.9 million excluding non-melanoma skin cancer) which has occurred in 2020.
IVD antibodies & immunoassays are widely used to detect several cancers including breast cancer, melanoma, leukemia, testicular, brain, liver, bladder and gastrointestinal cancer, among others. The early detection of the cancer may help to prevent the elevated life risk associated with it. Hence rising prevalence of cancer and use of IVD antibodies for the diagnosis of cancer and inflammation diseases drives the growth of IVD antibodies market.
Restraints for IVD Antibodies Market
-
High cost of IVD Kit.(Access Detailed Analysis in the Full Report Version)
Opportunities for IVD Antibodies Market
-
Increasing R&D investments.(Access Detailed Analysis in the Full Report Version)
We have various report editions of IVD Antibodies Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Company Profile
Thermo Fisher Scientific Inc.
Thermo Fischer Scientific Inc is engaged in the manufacturing and distribution of several products in the market. The brands offered by the portfolio include Thermo scientific, applied biosystem, Invitrogen, fisher scientific, unity labs services, and Patheon. The company develops HLA typing solutions in the market, which assist in the transplantation of organs. Additionally, the services offered by the company are custom service, enterprises, instrument service, and others.
RECENT NEWS
April 2021
Thermo Fisher Scientific Inc. acquired PPD Company
The company acquired PPPD, a clinical research organization that provide quality service in the market, this acquisition has accelerated innovation and increase drug development productivity, optimization in service ensuring customer satisfaction.
October 2020
Thermo Fischer Scientific Inc. engaged in partnership with Terasaki Innovation Center
Thermo Fischer Scientific Inc has engaged in partnership with Terasaki Innovation Center for facilitating development of new pathways and products to diagnose and manage transplantation of patients.
Rockland Immunochemical, Inc.
Rockland Immunochemical, Inc. is a United States based company involved in manufacturing of leading-edge tools for basic, applied, and clinical research in functional genomics, gene therapy, and drug discovery markets. The company is involved in the production of antibody and protein and offers more than 13,000 products. The company offers its products to serve industries including biopharma, diagnostics and agriculture.
RECENT NEWS
September 2021
Partnership in support of biotech expansion
Rockland has signed the long-term partnership for supporting key areas of research and development in the Kingdom of Saudi Arabia such as chronic and infectious diseases at Riyadh Global Medical Biotechnology Summit.
October 2021
Rockland expanded infectious disease portfolio with new partner, Diagnostic BioSystems
Rockland Immunochemicals, Inc. has signed distribution agreement with Diagnostic BioSystems (DBS) which is expected to enables greater accessibility of select infectious disease antibodies that have been optimized for high-quality staining in immunohistochemical applications.
Diagnostic BioSystems (DBS) is a provider of cutting-edge in vitro diagnostics and high quality Immunohistochemistry (IHC) reagents.
Top Companies Market Share in IVD Antibodies Industry: (In no particular order of Rank)
- Abcam plc.
- Thermo Fisher Scientific
- Rockland Immunochemicals Inc.
- GenScript
- Bio-Rad Laboratories Inc.
- SDIX LLC.
- Advy Chemical Pvt. Ltd.
- MEDICAL & BIOLOGICAL LABORATORIES CO. LTD.
- HyTest Ltd.
- Abbott
- Others
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
The North America IVD Antibodies Market dominates overall market:
The North America IVD Antibodies market size will be USD 9,816.74 Million by 2028.
North America is dominated the IVD antibodies market with significant market share. This is attributed to the rising healthcare expenditure in region. According to National Health Expenditure Accounts (NHEA) the total health care spending in the United States grew 9.7 percent in 2020 as compare to 2019, reaching $4.1 trillion or $12,530 per person. This also results in rising research and development activities which in turn drive the IVD antibodies market in the North America.
The current report Scope analyzes IVD Antibodies Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
IVD Antibodies Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
IVD Antibodies Market Analysis
Global IVD Antibodies Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing IVD Antibodies Industry growth. IVD Antibodies market has been segmented with the help of its Type, Application End User, and others. IVD Antibodies market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Type analysis of IVD Antibodies market.
Cardiac Markers
The Cardiac Markers segment Revenue will beUSD 8,239.30 Million by 2028.
Cardiac biomarkers are protein-based molecules that are employed in the diagnosis and prognosis of cardiovascular illnesses as indicators of biologic status. Their measurement can aid in the diagnosis of a disorder. Increased levels of these biomarkers can suggest the existence and risk of cardiovascular disease. Cardiac biomarkers are widely employed as point-of-care (POC) testing, which allows for speedy findings in emergency settings. They are also being used in a rising number of emergency departments.
Tumor Markers
Tumor markers are proteins generated by cancer cells or other body cells in response to cancer or some benign (noncancerous) diseases. Tumor-associated antigens (TAAs) and their antibodies have been discovered as potential cancer diagnostic and prognostic indicators. The use of antibodies to identify cancer markers is a common method in cancer diagnoses, screening, and research. Tumor marker-specific antibodies can be used to identify high levels of tumour markers in a patient's blood, urine, or tissue, which can help with cancer diagnosis and prognosis.
Kidney Injury Markers
Acute kidney injury (AKI) is defined as a sudden decrease of kidney function that occurs over a short period of time. Several indicators, such as NGAL and cystatin C, have been proposed to diagnose this kidney injury. Changes in the levels of these biomarkers in both blood and urine can be observed within 2 hours. It can be utilized for early AKI diagnosis, risk stratification, clinical outcome prediction, and therapeutic response monitoring.
Infection and Inflammation Antibodies
Antibodies are employed in a variety of IVD procedures to detect and quantify specific target molecules. It is used to identify infection or inflammation, to differentiate between bacterial and viral or fungal disease, to assess severity, and to guide therapy. Antigens from bacteria or viruses can be utilized to detect an infection, as well as cytokines that can be measured to diagnose an inflammatory or autoimmune disease. By functioning as an early warning sign of acute inflammation, these antibodies can aid in the treatment of critically ill patients
IVD Antibodies Market Share (%) by Type in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of IVD Antibodies Industry. Request a Free Sample PDF!
IVD Antibodies Market, by application
Immunology
The Immunology segment Revenue in IVD Antibodies will be USD 9,127.89 Million by 2028.
Immunology is a biomedical science that investigates an organism's immune response to the original material and its procedures. IVD antibodies are commonly employed in immunology procedures such as immunonephelometry and sandwich ELISA. Monoclonal antibodies can detect the surface molecules of diverse immune cells and other tissues, which is useful for isolating, identifying, and classifying immune cells, as well as studying the structure and function of various membrane surface molecules.
Cancer
Cancer is one of the top causes of death worldwide. The increased number of cancer patients necessitates the development of innovative cancer diagnostic techniques. IVD antibodies are important in cancer screening, diagnosis, and treatment because they drive clinical decision-making. The IVD antibodies are designed to help in cancer subtype detection and categorization. It was created to fight a variety of illness biomarkers.
Cardiovascular Diseases
In vitro diagnostics (IVD) at the point-of-care are now the most used methods for identifying CVD. As the frequency of cardiovascular illnesses rises, IVD antibodies are increasingly being employed. Antibodies have great specificity and sensitivity, allowing for reliable detection of even low-abundance analytes in a variety of cardiac sample types.
Others
Several other diseases such as bone metabolism, fertility & pregnancy care, and others employ IVD antibodies. Similarly, there are several commonly used immunoassays for hormone detection, including enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLISA), and lateral flow assay (LFA) are used.
IVD Antibodies Market Share (%) by Application in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
IVD Antibodies End User Segment Analysis
Diagnostic Laboratories
The Diagnostic Laboratories segment Revenue in IVD Antibodies will be USD 8,544.16 Million in 2028.
Antibodies used in the laboratory to identify sickness, infections, and other medical disorders are known as in vitro diagnostics (IVD). These labs are frequently equipped with IVD instruments, reagents, software, and services to identify illness using IVD antibodies
Hospitals
In hospitals, in vitro diagnostic tests are employed. The IVD antibodies diagnostic enables clinicians to accurately identify patients and give suitable therapy. This is especially useful at hospitals in low- and middle-income countries. These nations frequently lack an integrated network of laboratories for such testing; nonetheless, a wide range of IVDs are accessible for testing patients in hospitals when laboratories are unavailable
Homecare settings
The IVD antibodies required for patients' treatment have been created when they transition to using home health care services for recovery or long-term care. The samples obtained, such as blood and urine, are tested at these home healthcare services.
Others
IVD antibodies are used by a variety of additional end users, including academic and research institutions. Novel medicines for cardiovascular disease, cancer, immunology, and a variety of other disorders are the focus of several university and government research centres. As a result, there is a growing emphasis on antibodies for in vitro diagnostics.
- Diagnostic Laboratories
- Hospitals
- Homecare settings
- Others
Author's Detail
Manjiri KanhereSenior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
- The Global IVD Antibodies Market revenue in 2016: USD 12,453.87 Million
- Tumor Markets held for largest share of total revenue generated in 2019
- Cancer held maximum share of IVD Antibodies market in 2019
- Hospitals held maximum share revenue in 2019
- Rising prevalence of cancer and use of IVD antibodies for the diagnosis of cancer and inflammation diseases drives the growth of IVD antibodies market
- Rise in geriatric population drives the market for IVD antibodies
- However, on-going R&D activities and major focus of manufacturers towards inventing low-cost but effective kits will propel the further growth of market in the near future
- Investment in research and development of IVD to satisfy the ever increasing demand of the diagnostic measures will create lucrative opportunity for the IVD antibodies market
Frequently Asked Questions (FAQs)
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about IVD Antibodies Market
Sources from Pharma & Healthcare Industry
- https://en.wikipedia.org/wiki/American_Society_for_Pharmacy_Law
- https://en.wikipedia.org/wiki/American_Society_of_Consultant_Pharmacists
- https://en.wikipedia.org/wiki/American_Society_of_Health-System_Pharmacists
- https://www.apsm-uk.com/
- https://en.wikipedia.org/wiki/Australasian_College_of_Pharmacy
- https://en.wikipedia.org/wiki/American_Association_of_Colleges_of_Pharmacy
- https://en.wikipedia.org/wiki/American_College_of_Clinical_Pharmacy
- https://en.wikipedia.org/wiki/American_Pharmacists_Association
- https://www.bio.org/
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Association
- https://en.wikipedia.org/wiki/Canadian_Society_of_Hospital_Pharmacists
- https://en.wikipedia.org/wiki/Chinese_Pharmaceutical_Association
- https://en.wikipedia.org/wiki/American_Association_of_Psychiatric_Pharmacists
- https://en.wikipedia.org/wiki/Danish_Association_of_Pharmaconomists
- https://en.wikipedia.org/wiki/EPhEU
- https://www.fda.gov/
- https://www.gmc-uk.org/
- https://www.ifpma.org/
- https://www.fip.org/
- https://en.wikipedia.org/wiki/International_Pharmaceutical_Students%27_Federation
- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
- https://en.wikipedia.org/wiki/National_Pharmacy_Association
- https://en.wikipedia.org/wiki/Norwegian_Pharmacy_Association
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Journal#History
- https://en.wikipedia.org/wiki/Pakistan_Pharmacists_Association
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Mauritius
- https://en.wikipedia.org/wiki/Pharmaceutical_Group_of_the_European_Union
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Australia
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_New_Zealand
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Northern_Ireland
- https://en.wikipedia.org/wiki/Professional_Compounding_Centers_of_America
- https://en.wikipedia.org/wiki/Royal_Pharmaceutical_Society
- https://www.aaps.org/home
- https://www.bioindustry.org/
- https://www.controlledreleasesociety.org/
- https://www.efpia.eu/
- https://www.epemed.org/online/www/content/ENG/index.html
- https://icr-global.org/
- https://ispe.org/
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Israel
- https://www.phrma.org/
- https://en.wikipedia.org/wiki/The_Pharmacy_Guild_of_Australia
- https://en.wikipedia.org/wiki/The_Society_of_Hospital_Pharmacists_of_Australia
- https://en.wikipedia.org/wiki/Healthcare_industry
- https://www.pharma-iq.com/business-development/articles/top-50-pharmaceutical-blogs-and-publications
- https://www.pharmatimes.com/news
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967517/
- https://www.cbo.gov/publication/57126
- http://: https://www.who.int/tools/atc-ddd-toolkit/data
- https://www.oecd.org/els/health-systems/health-data.htm
- https://www.bls.gov/ooh/healthcare/home.htm
- https://data.worldbank.org/topic/8
- https://www.statnews.com/about/
- https://www.health.pa.gov/topics/HealthStatistics/Pages/health-statistics.aspx
- https://www.cdc.gov/nchs/index.htm
- https://www.aha.org/statistics/fast-facts-us-hospitals
- https://www.census.gov/library/publications/2021/demo/p60-274.html
- https://www.adb.org/what-we-do/sectors/health/main
IVD Antibodies Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Type | Cardiac Markers, Tumor Markers, Kidney Injury Markers, Infection and Inflammation Antibodies |
| Application | Immunology, Cancer, Cardiovascular Diseases, Others |
| End User | Diagnostic Laboratories, Hospitals, Homecare settings, Others |
| List of Competitors | Abcam plc., Thermo Fisher Scientific, Rockland Immunochemicals Inc., GenScript, Bio-Rad Laboratories Inc., SDIX LLC., Advy Chemical Pvt. Ltd., MEDICAL & BIOLOGICAL LABORATORIES CO. LTD., HyTest Ltd., Abbott, Others |
This chapter will help you gain GLOBAL Market Analysis of IVD Antibodies. Further deep in this chapter, you will be able to review Global IVD Antibodies Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global IVD Antibodies Revenue Market Size, Trend Analysis 2019 - 2031
-
1.2 Global IVD Antibodies Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global IVD Antibodies Revenue Market Size By Region
-
-
1.3 Global IVD Antibodies Market Size By Type 2019 -2031
-
1.3.1 Cardiac Markers Market Size
-
1.3.2 Tumor Markers Market Size
-
1.3.3 Kidney Injury Markers Market Size
-
1.3.4 Infection and Inflammation Antibodies Market Size
-
-
1.4 Global IVD Antibodies Market Size By Application 2019 -2031
-
1.4.1 Immunology Market Size
-
1.4.2 Cancer Market Size
-
1.4.3 Cardiovascular Diseases Market Size
-
1.4.4 Others Market Size
-
-
1.5 Global IVD Antibodies Market Size By End User 2019 -2031
-
1.5.1 Diagnostic Laboratories Market Size
-
1.5.2 Hospitals Market Size
-
1.5.3 Homecare settings Market Size
-
1.5.4 Others Market Size
-
-
1.6 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.7 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.7.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.7.2 Global Market Revenue Split By Type
-
1.7.3 Global Market Revenue Split By Application
-
1.7.4 Global Market Revenue Split By End User
-
1.7.5 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
This chapter will help you gain North America Market Analysis of IVD Antibodies. Further deep in this chapter, you will be able to review North America IVD Antibodies Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
-
2.1 North America IVD Antibodies Market Size 2019 - 2031
-
2.1.1 North America IVD Antibodies Market Size By Country 2019 - 2031
-
2.1.2 North America IVD Antibodies Market Size by Type 2019 -2031
-
2.1.2.1 North America Cardiac Markers Market Size
-
2.1.2.2 North America Tumor Markers Market Size
-
2.1.2.3 North America Kidney Injury Markers Market Size
-
2.1.2.4 North America Infection and Inflammation Antibodies Market Size
-
-
2.1.3 North America IVD Antibodies Market Size by Application 2019 -2031
-
2.1.3.1 North America Immunology Market Size
-
2.1.3.2 North America Cancer Market Size
-
2.1.3.3 North America Cardiovascular Diseases Market Size
-
2.1.3.4 North America Others Market Size
-
-
2.1.4 North America IVD Antibodies Market Size by End User 2019 -2031
-
2.1.4.1 North America Diagnostic Laboratories Market Size
-
2.1.4.2 North America Hospitals Market Size
-
2.1.4.3 North America Homecare settings Market Size
-
2.1.4.4 North America Others Market Size
-
-
This chapter will help you gain Europe Market Analysis of IVD Antibodies. Further deep in this chapter, you will be able to review Europe IVD Antibodies Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
-
3.1 Europe IVD Antibodies Market Size 2019 - 2031
-
3.1.1 Europe IVD Antibodies Market Size By Country 2019 - 2031
-
3.1.2 Europe IVD Antibodies Market Size by Type 2019 -2031
-
3.1.2.1 Europe Cardiac Markers Market Size
-
3.1.2.2 Europe Tumor Markers Market Size
-
3.1.2.3 Europe Kidney Injury Markers Market Size
-
3.1.2.4 Europe Infection and Inflammation Antibodies Market Size
-
-
3.1.3 Europe IVD Antibodies Market Size by Application 2019 -2031
-
3.1.3.1 Europe Immunology Market Size
-
3.1.3.2 Europe Cancer Market Size
-
3.1.3.3 Europe Cardiovascular Diseases Market Size
-
3.1.3.4 Europe Others Market Size
-
-
3.1.4 Europe IVD Antibodies Market Size by End User 2019 -2031
-
3.1.4.1 Europe Diagnostic Laboratories Market Size
-
3.1.4.2 Europe Hospitals Market Size
-
3.1.4.3 Europe Homecare settings Market Size
-
3.1.4.4 Europe Others Market Size
-
-
This chapter will help you gain Asia Pacific Market Analysis of IVD Antibodies. Further deep in this chapter, you will be able to review Asia Pacific IVD Antibodies Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific IVD Antibodies Market Size 2019 - 2031
-
4.1.1 Asia Pacific IVD Antibodies Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific IVD Antibodies Market Size by Type 2019 -2031
-
4.1.2.1 Asia Pacific Cardiac Markers Market Size
-
4.1.2.2 Asia Pacific Tumor Markers Market Size
-
4.1.2.3 Asia Pacific Kidney Injury Markers Market Size
-
4.1.2.4 Asia Pacific Infection and Inflammation Antibodies Market Size
-
-
4.1.3 Asia Pacific IVD Antibodies Market Size by Application 2019 -2031
-
4.1.3.1 Asia Pacific Immunology Market Size
-
4.1.3.2 Asia Pacific Cancer Market Size
-
4.1.3.3 Asia Pacific Cardiovascular Diseases Market Size
-
4.1.3.4 Asia Pacific Others Market Size
-
-
4.1.4 Asia Pacific IVD Antibodies Market Size by End User 2019 -2031
-
4.1.4.1 Asia Pacific Diagnostic Laboratories Market Size
-
4.1.4.2 Asia Pacific Hospitals Market Size
-
4.1.4.3 Asia Pacific Homecare settings Market Size
-
4.1.4.4 Asia Pacific Others Market Size
-
-
This chapter will help you gain South America Market Analysis of IVD Antibodies. Further deep in this chapter, you will be able to review South America IVD Antibodies Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
-
5.1 South America IVD Antibodies Market Size 2019 - 2031
-
5.1.1 South America IVD Antibodies Market Size By Country 2019 - 2031
-
5.1.2 South America IVD Antibodies Market Size by Type 2019 -2031
-
5.1.2.1 South America Cardiac Markers Market Size
-
5.1.2.2 South America Tumor Markers Market Size
-
5.1.2.3 South America Kidney Injury Markers Market Size
-
5.1.2.4 South America Infection and Inflammation Antibodies Market Size
-
-
5.1.3 South America IVD Antibodies Market Size by Application 2019 -2031
-
5.1.3.1 South America Immunology Market Size
-
5.1.3.2 South America Cancer Market Size
-
5.1.3.3 South America Cardiovascular Diseases Market Size
-
5.1.3.4 South America Others Market Size
-
-
5.1.4 South America IVD Antibodies Market Size by End User 2019 -2031
-
5.1.4.1 South America Diagnostic Laboratories Market Size
-
5.1.4.2 South America Hospitals Market Size
-
5.1.4.3 South America Homecare settings Market Size
-
5.1.4.4 South America Others Market Size
-
-
This chapter will help you gain Middle East and Africa Market Analysis of IVD Antibodies. Further deep in this chapter, you will be able to review Middle East and Africa IVD Antibodies Market Split by various segments and Country Split.
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa IVD Antibodies Market Size 2019 - 2031
-
6.1.1 Middle East and Africa IVD Antibodies Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa IVD Antibodies Market Size by Type 2019 -2031
-
6.1.2.1 Middle East and Africa Cardiac Markers Market Size
-
6.1.2.2 Middle East and Africa Tumor Markers Market Size
-
6.1.2.3 Middle East and Africa Kidney Injury Markers Market Size
-
6.1.2.4 Middle East and Africa Infection and Inflammation Antibodies Market Size
-
-
6.1.3 Middle East and Africa IVD Antibodies Market Size by Application 2019 -2031
-
6.1.3.1 Middle East and Africa Immunology Market Size
-
6.1.3.2 Middle East and Africa Cancer Market Size
-
6.1.3.3 Middle East and Africa Cardiovascular Diseases Market Size
-
6.1.3.4 Middle East and Africa Others Market Size
-
-
6.1.4 Middle East and Africa IVD Antibodies Market Size by End User 2019 -2031
-
6.1.4.1 Middle East and Africa Diagnostic Laboratories Market Size
-
6.1.4.2 Middle East and Africa Hospitals Market Size
-
6.1.4.3 Middle East and Africa Homecare settings Market Size
-
6.1.4.4 Middle East and Africa Others Market Size
-
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1IVD Antibodies Market Size by Type 2019 -2031
-
7.1.2 Country 1IVD Antibodies Market Size by Application 2019 -2031
-
7.1.3 Country 1IVD Antibodies Market Size by End User 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
This chapter provides an in-depth analysis of the market share among key competitors of IVD Antibodies. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global IVD Antibodies Market Revenue and Share by Key Players
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 Abcam plc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 Thermo Fisher Scientific
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 Rockland Immunochemicals Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 GenScript
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 Bio-Rad Laboratories Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 SDIX LLC.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 Advy Chemical Pvt. Ltd.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 MEDICAL & BIOLOGICAL LABORATORIES CO. LTD.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 HyTest Ltd.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 Abbott
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
8.2.11 Others
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.11.2 Business Overview
-
8.2.11.3 Financials (Subject to data availability)
-
8.2.11.4 Product Types Specification
-
8.2.11.5 Business Strategy
-
8.2.11.6 S.W.O.TAnalysis
-
-
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Restraints
-
9.3 Market Trends
-
9.4 Market Opportunity
-
9.5 Technological Road Map (Subject to Data Availability)
-
9.6 Product Life Cycle (Subject to Data Availability)
-
9.7 Consumer Preference Analysis
-
9.8 Market Attractiveness Analysis
-
9.9 PESTEL Analysis
-
9.9.1 Political Factors
-
9.9.2 Economic Factors
-
9.9.3 Social Factors
-
9.9.4 Technological Factors
-
9.9.5 Legal Factors
-
9.9.6 Environmental Factors
-
-
9.10 Industrial Chain Analysis (Subject to Data Availability)
-
9.10.1 Industry Chain Analysis
-
9.10.2 Manufacturing Cost Analysis
-
9.10.3 Supply Side Analysis
-
9.10.3.1 Raw Material Analysis
-
9.10.3.2 Raw Material Procurement Analysis
-
9.10.3.3 Raw Material Price Trend Analysis
-
-
-
9.11 Porter’s Five Forces Analysis
-
9.11.1 Bargaining Power of Suppliers
-
9.11.2 Bargaining Power of Buyers
-
9.11.3 Threat of New Entrants
-
9.11.4 Threat of Substitutes
-
9.11.5 Degree of Competition
-
-
9.12 Patent Analysis (Subject to Data Availability)
-
9.13 ESG Analysis
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2019 -2031
-
10.1 Cardiac Markers
-
10.1.1 Global IVD Antibodies Revenue Market Size and Share by Cardiac Markers 2019 -2031
-
-
10.2 Tumor Markers
-
10.2.1 Global IVD Antibodies Revenue Market Size and Share by Tumor Markers 2019 -2031
-
-
10.3 Kidney Injury Markers
-
10.3.1 Global IVD Antibodies Revenue Market Size and Share by Kidney Injury Markers 2019 -2031
-
-
10.4 Infection and Inflammation Antibodies
-
10.4.1 Global IVD Antibodies Revenue Market Size and Share by Infection and Inflammation Antibodies 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2019 -2031
-
11.1 Immunology
-
11.1.1 Global IVD Antibodies Revenue Market Size and Share by Immunology 2019 - 2031
-
-
11.2 Cancer
-
11.2.1 Global IVD Antibodies Revenue Market Size and Share by Cancer 2019 - 2031
-
-
11.3 Cardiovascular Diseases
-
11.3.1 Global IVD Antibodies Revenue Market Size and Share by Cardiovascular Diseases 2019 - 2031
-
-
11.4 Others
-
11.4.1 Global IVD Antibodies Revenue Market Size and Share by Others 2019 - 2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by End User Analysis 2019 -2031
-
12.1 Diagnostic Laboratories
-
12.1.1 Global IVD Antibodies Revenue Market Size and Share by Diagnostic Laboratories 2019 -2031
-
-
12.2 Hospitals
-
12.2.1 Global IVD Antibodies Revenue Market Size and Share by Hospitals 2019 -2031
-
-
12.3 Homecare settings
-
12.3.1 Global IVD Antibodies Revenue Market Size and Share by Homecare settings 2019 -2031
-
-
12.4 Others
-
12.4.1 Global IVD Antibodies Revenue Market Size and Share by Others 2019 -2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global IVD Antibodies market
Chapter 13 Research Findings
-
13.1 Key Takeaways
-
13.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
13.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Manjiri Kanhere and Team
- 1.1 IVD Antibodies Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for IVD Antibodies Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for IVD Antibodies Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for IVD Antibodies Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for IVD Antibodies Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for IVD Antibodies Market
Key Questions Answered By IVD Antibodies Market Report 2024
| Why Cardiac Markers have a significant impact on IVD Antibodies market? |
| What are the key factors affecting the Cardiac Markers and Tumor Markers of IVD Antibodies Market? |
| What is the CAGR/Growth Rate of Immunology during the forecast period? |
| By type, which segment accounted for largest share of the global IVD Antibodies Market? |
| Which region is expected to dominate the global IVD Antibodies Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
